Low‐dose computed tomography (LDCT) screening vs no LDCT screening
Number of invasive tests Time point: 3 years to 10 years from randomisation  · healthy adults
1 finding from 1 review
- Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality 2022 · Cochrane Headline outcomes only2.6 [2.41, 2.8]3 studies · 60003 participantsModerate